These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6173114)

  • 1. Dose- and schedule-dependent activation and drug synergism between thymidine and 5-aza-2'-deoxycytidine in a human promyelocytic leukemia cell line.
    Grant S; Rauscher F; Margolin J; Cadman E
    Cancer Res; 1982 Feb; 42(2):519-24. PubMed ID: 6173114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of in vitro and in vivo effects of thymidine on L1210 leukemia in mice.
    Zaharko DS; Ramonas LM
    J Natl Cancer Inst; 1982 May; 68(5):875-80. PubMed ID: 6951095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of DNA methylation in L1210 leukemic cells by 5-aza-2'-deoxycytidine as a possible mechanism of chemotherapeutic action.
    Wilson VL; Jones PA; Momparler RL
    Cancer Res; 1983 Aug; 43(8):3493-6. PubMed ID: 6190553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 5-aza-2'-deoxycytidine on survival and cell cycle progression of L1210 leukemia cells.
    Chabot GG; Momparler RL
    Leuk Res; 1986; 10(5):533-7. PubMed ID: 2423812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of deoxycytidine metabolism in vivo with high-dose thymidine in mice.
    Zaharko DS; Covey JM
    J Natl Cancer Inst; 1983 Nov; 71(5):1033-9. PubMed ID: 6580479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in DNA damage produced by incorporation of 5-aza-2'-deoxycytidine or 5,6-dihydro-5-azacytidine into DNA of mammalian cells.
    Covey JM; D'Incalci M; Tilchen EJ; Zaharko DS; Kohn KW
    Cancer Res; 1986 Nov; 46(11):5511-7. PubMed ID: 2428479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of deoxycytidine on the metabolism and cytotoxicity of 5-aza-2'-deoxycytidine and arabinosyl 5-azacytosine in normal and leukemic human myeloid progenitor cells.
    Bhalla K; Cole J; MacLaughlin W; Arlin Z; Baker M; Graham G; Grant S
    Leukemia; 1987 Dec; 1(12):814-9. PubMed ID: 2447450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2',3'-Dideoxycytidine: regulation of its metabolism and anti-retroviral potency by natural pyrimidine nucleosides and by inhibitors of pyrimidine nucleotide synthesis.
    Balzarini J; Cooney DA; Dalal M; Kang GJ; Cupp JE; DeClercq E; Broder S; Johns DG
    Mol Pharmacol; 1987 Dec; 32(6):798-806. PubMed ID: 2826994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic action of 5-aza-2'-deoxycytidine and 3-deazauridine on L1210 leukemic cells and EMT6 tumor cells.
    Momparler RL; Veselý J; Momparler LF; Rivard GE
    Cancer Res; 1979 Oct; 39(10):3822-7. PubMed ID: 476619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic and cytokinetic effects of thymidine, 5-fluorouracil, and deoxycytidine on HeLa cells in culture.
    Fried J; Perez AG; Doblin JM; Clarkson BD
    Cancer Res; 1981 Jul; 41(7):2627-32. PubMed ID: 7248935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of deoxynucleosides on cultured human leukemia cell growth and deoxynucleotide pools.
    Ross DD; Akman SA; Schrecker AW; Bachur NR
    Cancer Res; 1981 Nov; 41(11 Pt 1):4493-8. PubMed ID: 6975653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential affinities of pyrimidine nucleoside analogues for deoxythymidine and deoxycytidine kinase determine their incorporation into murine leukemia L1210 cells.
    Balzarini J; De Clercq E
    Acta Biochim Pol; 1987; 34(2):63-77. PubMed ID: 2823514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deoxyribonucleoside-induced selective modulation of cytotoxicity and mutagenesis.
    Peterson AR; Danenberg PV; Ibric LL; Peterson H
    Basic Life Sci; 1985; 31():313-34. PubMed ID: 3158302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity by 2,3-dihydro-1H-imidazolo[1,2-b]pyrazole in the human promyelocytic leukemic cell, HL-60.
    Grant S; Bhalla K; Rauscher F; Cadman E
    Cancer Res; 1983 Nov; 43(11):5093-100. PubMed ID: 6577943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incorporation of a potent antileukemic agent, 5-aza-2'-deoxycytidine, into DNA of cells from leukemic mice.
    Veselý J; Cihák A
    Cancer Res; 1977 Oct; 37(10):3684-9. PubMed ID: 71199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3-Deazauridine enhances the antileukemic action of 5-aza-2'-deoxycytidine and targets drug-resistance due to deficiency in deoxycytidine kinase.
    Raynal NJ; Momparler LF; Rivard GE; Momparler RL
    Leuk Res; 2011 Jan; 35(1):110-8. PubMed ID: 20510451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of 1-beta-D-arabinofuranosyl-5-azacytosine and incorporation into DNA of human T-lymphoblastic cells (Molt-4).
    Townsend A; Leclerc JM; Dutschman G; Cooney D; Cheng YC
    Cancer Res; 1985 Aug; 45(8):3522-8. PubMed ID: 2410096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of deoxycytidine kinase by 5-azacytidine in an HL-60 cell line resistant to arabinosylcytosine.
    Kong XB; Tong WP; Chou TC
    Mol Pharmacol; 1991 Feb; 39(2):250-7. PubMed ID: 1705001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological characterization of a prolonged antileukemic effect of 5-azacytidine.
    Presant CA; Valeriote F; Vietti TJ
    Cancer Res; 1977 Feb; 37(2):376-81. PubMed ID: 64294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I and pharmacokinetic study of 5-aza-2'-deoxycytidine (NSC 127716) in cancer patients.
    van Groeningen CJ; Leyva A; O'Brien AM; Gall HE; Pinedo HM
    Cancer Res; 1986 Sep; 46(9):4831-6. PubMed ID: 2425959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.